|
regulation of apoptotic process involved in outflow tract morphogenesis
|
GO_1902256 |
[Any process that modulates the frequency, rate or extent of apoptotic process involved in outflow tract morphogenesis.] |
|
regulation of apoptotic process involved in morphogenesis
|
GO_1902337 |
[Any process that modulates the frequency, rate or extent of apoptotic process involved in morphogenesis.] |
|
negative regulation of apoptotic process involved in outflow tract morphogenesis
|
GO_1902257 |
[Any process that stops, prevents or reduces the frequency, rate or extent of apoptotic process involved in outflow tract morphogenesis.] |
|
negative regulation of apoptotic process involved in morphogenesis
|
GO_1902338 |
[Any process that stops, prevents or reduces the frequency, rate or extent of apoptotic process involved in morphogenesis.] |
|
positive regulation of apoptotic process involved in outflow tract morphogenesis
|
GO_1902258 |
[Any process that activates or increases the frequency, rate or extent of apoptotic process involved in outflow tract morphogenesis.] |
|
positive regulation of apoptotic process involved in morphogenesis
|
GO_1902339 |
[Any process that activates or increases the frequency, rate or extent of apoptotic process involved in morphogenesis.] |
|
regulation of delayed rectifier potassium channel activity
|
GO_1902259 |
[Any process that modulates the frequency, rate or extent of delayed rectifier potassium channel activity.] |
|
regulation of cation channel activity
|
GO_2001257 |
[Any process that modulates the frequency, rate or extent of cation channel activity.] |
|
regulation of potassium ion transmembrane transporter activity
|
GO_1901016 |
[Any process that modulates the frequency, rate or extent of potassium ion transmembrane transporter activity.] |
|
hepatocyte dedifferentiation
|
GO_1990828 |
[The process in which a hepatocyte (specialized epithelial cell of the liver) loses the structural or functional features that characterize it in the mature organism, or some other relatively stable phase of the organism's life history. Under certain conditions, these cells can revert back to the features of the stem cells that were their ancestors.] |
|
cell dedifferentiation
|
GO_0043697 |
[The process in which a specialized cell loses the structural or functional features that characterize it in the mature organism, or some other relatively stable phase of the organism's life history. Under certain conditions, these cells can revert back to the features of the stem cells that were their ancestors.] |
|
C-rich single-stranded DNA binding
|
GO_1990829 |
[Binding to C-rich, single-stranded DNA.] |
|
single-stranded DNA binding
|
GO_0003697 |
[Binding to single-stranded DNA.] |
|
nucleoplasmic periphery of the nuclear pore complex
|
GO_1990826 |
[Nucleoplasm situated in close proximity and peripheral to a nuclear pore complex.] |
|
deaminase binding
|
GO_1990827 |
[Binding to an enzyme that catalyzes the removal of an amino group from a substrate, producing ammonia (NH3).] |
|
obsolete magnesium-dependent protein complex
|
GO_1990824 |
[OBSOLETE. A protein complex that depends on magnesium in order for one or more of its components to remain a part of the complex.] |
|
sequence-specific mRNA binding
|
GO_1990825 |
[Binding to messenger RNA (mRNA) of a specific nucleotide composition or a specific sequence motif.] |
|
basic amino acid transport
|
GO_0015802 |
[The directed movement of basic amino acids, amino acids with a pH above 7, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.] |
|
response to leukemia inhibitory factor
|
GO_1990823 |
[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a leukemia inhibitory factor stimulus.] |
|
response to mitotic DNA integrity checkpoint signaling
|
GO_1990820 |
[A process that occurs in response to signals generated as a result of mitotic DNA integrity checkpoint signaling.] |